Skip to main content
Log in

Combined Therapy of Voriconazole and Anidulafungin in Murine Infections by Aspergillus flavus

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

The efficacy of the combination of anidulafungin (AFG) at 1 mg/kg plus voriconazole (VRC) at 25 mg/kg was evaluated in a murine model of disseminated infection by Aspergillus flavus using three isolates previously tested in vitro. All the combinations showed indifferent in vitro interaction with the exception of one, which showed synergy. In general, the combined treatment prolonged the survival and reduced the fungal load in comparison with AFG alone, and only in a few cases, it improved the results of the VRC monotherapy. The combination of the two drugs and VRC alone reduced the galactomannan levels in serum in comparison with the control group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Marr KA. Fungal infections in hematopoietic stem cell transplant recipients. Med Mycol. 2008;46:293–302.

    Article  PubMed  Google Scholar 

  2. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF. Treatment of aspergillosis: clinical practice guideline of the infectious diseases society of America. Clin Infect Dis. 2008;46:327–60.

    Article  PubMed  CAS  Google Scholar 

  3. Marr KA, Boeckh M, Carter RA, Kim HW, Corey L. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis. 2004;39:797–802.

    Article  PubMed  CAS  Google Scholar 

  4. Johnson MD, MacDougall C, Ostrosky-Zeichner L, Perfect JR, Rex JH. Combination antifungal therapy. Antimicrob Agents Chermother. 2004;48:693–715.

    Article  CAS  Google Scholar 

  5. Perkhofer S, Lass-Flörl C. Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination. Expert Opin Investig Drugs. 2009;18:1393–404.

    Article  PubMed  CAS  Google Scholar 

  6. Calvo E, Pastor FJ, Mayayo E, Salas V, Guarro J. In vitro and in vivo efficacy of anidulafungin in murine infections by Aspergillus flavus. Antimicrob Agents Chemother. 2011;55:1290–2.

    Article  PubMed  CAS  Google Scholar 

  7. Calvo E, Pastor FJ, Mayayo E, Guarro J. Efficacy of anidulafungin against Aspergillus niger in vitro and in vivo. Int J Antimicrob Agents. 2011;38:360–3.

    Article  PubMed  CAS  Google Scholar 

  8. Guarro J. Lessons from animal studies for the treatment of invasive human infections due to uncommon fungi. J Antimicrob Chemother. 2011;66:1447–66.

    Article  PubMed  CAS  Google Scholar 

  9. Pastor FJ, Guarro J. Anidulafungin: experimental therapy of fungal infections in animal models. Rev Iberoam Micol. 2008;25:119–23.

    Article  PubMed  Google Scholar 

  10. Vazquez JA. The safety of anidulafungin. Expert Opin Drug Saf. 2006;5:751–8.

    Article  PubMed  CAS  Google Scholar 

  11. Laboratory Clinical Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved Standard-Second Edition. CLSI document M38–A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.

    Google Scholar 

  12. Dannaoui E, Lortholary O, Dromer F. In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus. Antimicrob Agents Chemother. 2004;48:970–8.

    Article  PubMed  CAS  Google Scholar 

  13. Arikan S, Lozano-Chiu M, Paetznick V, Rex JH. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob Agents Chemother. 2001;45:327–30.

    Article  PubMed  CAS  Google Scholar 

  14. Theuretzbacher U. Pharmacokinetics/pharmacodynamics of echinocandins. Eur J Microbiol Infect Dis. 2004;23:805–12.

    Article  CAS  Google Scholar 

  15. Warn PA, Sharp A, Mosquera J, Spickermann J, Schimitt-Hoffmann A, Heep M, Denning DW. Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus. J Antimicrob Chemother. 2006;58:1198–207.

    Article  PubMed  CAS  Google Scholar 

  16. Sugar AM, Liu XP. Effect of grapefruit juice on serum voriconazole concentrations in the mouse. Med Mycol. 2000;38:209–12.

    PubMed  CAS  Google Scholar 

  17. Dowell JA, Schranz J, Baruch A, Foster G. Safety and pharmacokinetics of coadministered voriconazole and anidulafungin. J Clin Pharmacol. 2005;45:1373–82.

    Article  PubMed  CAS  Google Scholar 

  18. Crandon JL, Banevicius MA, Fang AF, Crownover PH, Knauft RF, Pope JS, Russomanno JH, Shore E, Nicolau DP, Kuti JL. Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults. Antimicrob Agents Chemother. 2009;53:5102–7.

    Article  PubMed  CAS  Google Scholar 

  19. Shalit I, Shadkchan Y, Samra Z, Osherov N. In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points. Antimicrob Agents Chemother. 2003;47:1416–8.

    Article  PubMed  CAS  Google Scholar 

  20. Cuenca-Estrella M, Gomez-Lopez A, Garcia-Effron G, Alcazar-Fuoli L, Mellado E, Buitrago MJ, Rodriguez-Tudela JL. Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus. Antimicrob Agents Chemother. 2005;49:1232–5.

    Article  PubMed  CAS  Google Scholar 

  21. Pastor FJ, Guarro J. In vitro activity of the echinocandins. How should it be evaluated? Rev Iberoam Micol. 2005;22:133–40.

    Article  PubMed  Google Scholar 

  22. Kirkpatrick WR, Perea S, Coco BJ, Patterson TF. Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis. Antimicrob Agents Chemother. 2002;46:2564–8.

    Article  PubMed  CAS  Google Scholar 

  23. Perea S, Gonzalez G, Fothergill AW, Kirkpatrick WR, Rinaldi MG, Patterson TF. In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp. Antimicrob Agents Chemother. 2002;46:3039–41.

    Article  PubMed  CAS  Google Scholar 

  24. Philip A, Odabasi Z, Rodriguez J, Paetznick VL, Chen E, Rex JH, Ostrosky-Zeichner L. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp. Antimicrob Agents Chemother. 2005;49:3572–4.

    Article  PubMed  CAS  Google Scholar 

  25. Perkhofer S, Jost D, Dierich MP, Lass-Flörl C. Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions. Antimicrob Agents Chemother. 2008;52:1873–5.

    Article  PubMed  CAS  Google Scholar 

  26. Petraitis V, Petraitene R, Hope WW, Meletiadis J, Mickiene D, Hughes JE, Cotton MP, Stergiopoulou T, Kasai M, Francesconi A, Shaufele RL, Sein T, Avila NA, Bacher J, Walsh TJ. Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis. Antimicrob Agents Chemother. 2009;53:2382–91.

    Article  PubMed  CAS  Google Scholar 

  27. van de Sande WW, Mathotten RA, ten Kate MT, van Vianen W, Tavakol M, Rijnders BJ, Bakker-Woudenberg IA. Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin. Antimicrob Agents Chemother. 2009;53:2005–13.

    Article  PubMed  Google Scholar 

  28. Chandrasekar PH, Cutright JL, Manavathu EK. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis. Clin Microbiol Infect. 2004;10:925–8.

    Article  PubMed  CAS  Google Scholar 

  29. MacCallum DM, Whyte JA, Odds FC. Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis. Antimicrob Agents Chemother. 2005;49:3697–701.

    Article  PubMed  CAS  Google Scholar 

  30. Gubler C, Wildi SM, Imhof A, Schneemann M, Müllhaupt B. Disseminated invasive aspergillosis with cerebral involvement successfully treated with caspofungin and voriconazole. Infection. 2007;35:364–6.

    Article  PubMed  CAS  Google Scholar 

  31. Schuster F, Moelter C, Schmid I, Graubner UB, Kammer B, Belohradsky BH, Führer M. Successful antifungal combination therapy with voriconazole and caspofungin. Pediatr Blood Cancer. 2005;15:682–5.

    Article  Google Scholar 

  32. Singh N, Limaye AP, Forrest G, Safdar N, Muñoz P, Pursell K, Houston S, Rosso F, Montoya JG, Patton P, del Busto R, Aguado JM, Fisher RA, Klintmalm GB, Miller R, Wagener MM, Lewis RE, Kontoyiannis DP, Husain S. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation. 2006;81:320–6.

    Article  PubMed  CAS  Google Scholar 

  33. Thomas A, Korb V, Guillemain R, Caruba T, Boussaud V, Baillaud E, Prognon P, Begué D, Sabatier B. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis. J Clin Pharm Ther. 2010;35:49–53.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Josep Guarro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Calvo, E., Pastor, F.J., Salas, V. et al. Combined Therapy of Voriconazole and Anidulafungin in Murine Infections by Aspergillus flavus . Mycopathologia 173, 251–257 (2012). https://doi.org/10.1007/s11046-011-9507-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-011-9507-6

Keywords